156 related articles for article (PubMed ID: 38123199)
21. PDCD1 strengthens the sensitivity of ovarian cancer to cisplatin chemotherapy by promoting apoptosis.
Li Q; Gao JF; Qi BL
J BUON; 2017; 22(3):746-756. PubMed ID: 28730785
[TBL] [Abstract][Full Text] [Related]
22. [Expression of phosphatidylinositol-3 kinase in epithelial ovarian carcinoma].
Zhang PN; Sun H
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):196-200. PubMed ID: 17537308
[TBL] [Abstract][Full Text] [Related]
23. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
Chen J; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
[TBL] [Abstract][Full Text] [Related]
24. Ginkgo May Sensitize Ovarian Cancer Cells to Cisplatin: Antiproliferative and Apoptosis-Inducing Effects of Ginkgolide B on Ovarian Cancer Cells.
Jiang W; Cong Q; Wang Y; Ye B; Xu C
Integr Cancer Ther; 2014 May; 13(3):NP10-7. PubMed ID: 22505596
[TBL] [Abstract][Full Text] [Related]
25. [Study of growth, invasion and metastasis on ovarian epithelial cancer cell line with CCL18 over-expression by mediated in vitro].
Zhang W; Yang YZ; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):528-31. PubMed ID: 24284226
[TBL] [Abstract][Full Text] [Related]
26. Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase.
Cianfrocca R; Rosanò L; Spinella F; Di Castro V; Natali PG; Bagnato A
Can J Physiol Pharmacol; 2010 Aug; 88(8):796-801. PubMed ID: 20725137
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines].
Cheng G; Li Y; Tian F
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113
[TBL] [Abstract][Full Text] [Related]
28. [The effect of hydroxycamptothecin and topotecan to SKOV3 and CAOV3 in vitro].
Sun Z; Shen K; Xu X
Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):547-50. PubMed ID: 11360641
[TBL] [Abstract][Full Text] [Related]
29. miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.
Sestito R; Cianfrocca R; Rosanò L; Tocci P; Semprucci E; Di Castro V; Caprara V; Ferrandina G; Sacconi A; Blandino G; Bagnato A
Oncotarget; 2016 Jan; 7(4):4009-23. PubMed ID: 26675258
[TBL] [Abstract][Full Text] [Related]
30. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
[TBL] [Abstract][Full Text] [Related]
31. Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease.
Haley J; Tomar S; Pulliam N; Xiong S; Perkins SM; Karpf AR; Mitra S; Nephew KP; Mitra AK
Oncotarget; 2016 May; 7(22):32810-20. PubMed ID: 27147568
[TBL] [Abstract][Full Text] [Related]
32. [Target-specific cytotoxic activity of recombinant fusion toxin C-CPE-ETA' against CLDN-3,4-overexpressing ovarian cancer cells].
Yao Q; Zheng QM; Wen JF; Lü T; Wei MQ; Dai SZ
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):897-902. PubMed ID: 21223796
[TBL] [Abstract][Full Text] [Related]
33. [Alteration of survivin gene expression in ovarian cancer cell line CAOV3 after chemotherapy in vitro].
Zhang SL; Jiang T; Lin B; Zhao CQ; Meng LR
Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):482-5. PubMed ID: 15347474
[TBL] [Abstract][Full Text] [Related]
34. Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein.
Scoles DR; Xu X; Wang H; Tran H; Taylor-Harding B; Li A; Karlan BY
Gynecol Oncol; 2010 Jan; 116(1):109-16. PubMed ID: 19854496
[TBL] [Abstract][Full Text] [Related]
35. The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways.
Luo DH; Chen QY; Liu H; Xu LH; Zhang HZ; Zhang L; Tang LQ; Mo HY; Huang PY; Guo X; Mai HQ
J Transl Med; 2013 Aug; 11():203. PubMed ID: 23987636
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V
J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135
[TBL] [Abstract][Full Text] [Related]
37. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
[TBL] [Abstract][Full Text] [Related]
38. Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer.
Sestito R; Tocci P; Roman C; Di Castro V; Bagnato A
J Exp Clin Cancer Res; 2022 Apr; 41(1):157. PubMed ID: 35477522
[TBL] [Abstract][Full Text] [Related]
39. Effects of naringin on reversing cisplatin resistance and the Wnt/
Zhu H; Zou X; Lin S; Hu X; Gao J
J Int Med Res; 2020 Oct; 48(10):300060519887869. PubMed ID: 33086930
[TBL] [Abstract][Full Text] [Related]
40. An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles.
Joshi N; Liu D; Dickson KA; Marsh DJ; Ford CE; Stenzel MH
J Mater Chem B; 2021 Nov; 9(44):9123-9135. PubMed ID: 34676865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]